CIA
PFE icon

Cape Investment Advisory’s Pfizer PFE Stock Holding History

Cape Investment Advisory’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Sell
12,694
-700
-5% -$18.3K 0.08% 177
2026
Q1 		$376K Sell
13,394
-229
-2% -$6.1K 0.13% 147
2025
Q4 		$339K Buy
13,623
+6,932
+104% +$175K 0.1% 149
2025
Q3 		$170K Sell
6,691
-6,576
-50% -$162K 0.17% 125
2025
Q2 		$322K Sell
13,267
-3,417
-20% -$79.7K 0.12% 136
2025
Q1 		$423K Buy
16,684
+428
+3% +$11.2K 0.17% 106
2024
Q4 		$431K Buy
16,256
+179
+1% +$4.86K 0.17% 101
2024
Q3 		$465K Buy
16,077
+239
+2% +$6.97K 0.19% 92
2024
Q2 		$443K Buy
15,838
+3,520
+29% +$96.9K 0.2% 86
2024
Q1 		$342K Buy
12,318
+3,715
+43% +$103K 0.16% 104
2023
Q4 		$248K Buy
8,603
+459
+6% +$13.9K 0.12% 126
2023
Q3 		$270K Buy
8,144
+4,124
+103% +$146K 0.15% 103
2023
Q2 		$147K Sell
4,020
-5
-0.1% -$195 0.08% 165
2023
Q1 		$164K Buy
+4,025
New +$174K 0.1% 143

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cape Investment Advisory's PFE Position: Q2 2026 in Review

Cape Investment Advisory reduced its Pfizer (PFE) stake by 5.2% in Q2 2026, selling an estimated $18.3K and leaving 12,694 shares worth $306K. The position accounts for 0.08% of the portfolio, ranked #177.

Cape Investment Advisory first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $465K in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cape Investment Advisory held 12,694 shares of Pfizer worth $306K as of Q2 2026.
  • Cape Investment Advisory sold 700 Pfizer shares in Q2 2026, an estimated $18.3K.
  • Pfizer made up 0.08% of Cape Investment Advisory's portfolio in Q2 2026, its #177 holding.
  • Cape Investment Advisory first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • Cape Investment Advisory's Pfizer position peaked at $465K in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.